期刊文献+

矢状轴位胼胝体面积测量与脑脊液p-tau蛋白和Aβ_(1-42)含量对阿尔茨海默病早期诊断的价值 被引量:6

Study on the value of corpus callosum measurement combined with the assay of p-tau and Aβ_(1-42) concentrations in cerebral spinal fluid on early Alzheimer's disease diagnosis
原文传递
导出
摘要 目的评价矢状轴位磁共振成像(MRI)胼胝体面积测量和脑脊液 p-tau 蛋白及 Aβ_(1-42)含量对阿尔茨海默病(AD)早期诊断的价值。方法根据 NINCDS-ADRDA 标准诊断的25例可能AD,按 MMSE 评分分为2组:平均 MMSE 评分 AD1组为20.5±2.5;AD2组均为14.7±3,8。另设健康对照组,平均 MMSE 评分27.8±1.7。自动测量软件在 MRI 正中矢状位上对胼胝体面积直接测量。酶标记免疫吸附测定(ELISA)法对各组脑脊液中199位点磷酸化微管相关蛋白(p-tau199)和β-淀粉样蛋白1-42片段(Aβ_(1-42))含量测定。结果 AD1组的脑脊液中 p-tau199(pg/ml)为25.8±3.1,较对照组(17.7±1.5)增高,Aβ_(1-42)(pg/ml)为329.3±15.2,较对照组(522.5±15.1)降低,胼胝体面积较对照组缩小,但程度不显著。AD2组的胼胝体总面积较对照组明显缩小,以整个胼胝体缩小为特点,但尾部改变相对较轻;AD2组与 AD1组比较,p-tau 蛋白含量升高和 Aβ_(1-42)含量(pg/ml)降低的程度更明显,分别为31.3±4.8和318.5±30.8。结论胼胝体面积测量同时配合脑脊液 p-tau 蛋白和 Aβ_(1-42)含量的测定,不仅对确诊早期 AD 有帮助,而且能反映 AD 的病程变化。 Objective Study on the value of the corpus callosum measurement at mid-sagittal slice of magnetic resonance imaging (MRI) and the phosphorylated tan protein (p-tau) and Amyloid beta (Abeta) 1-42 immunoreactive deposits (Aβ1-42 )assay in cerebral spinal fluid (CSF) on early Alzheimer's disease (AD) diagnosis. Methods Consecutive probable AD diagnosed with the National institute of neurology and communication disorder and stroke- Alzheimer disease or AD related disease academy (NINCDS-ADRDA) criteria were divided into two groups according to MMSE score. The average MMSE score were 20. 5 ± 2.5 in group AD1 and 14. 7 ± 3. 8 in Group AD2, and was 27. 8 ± 1.7 in control group, which was well matched with the two AD groups in gender, age and education degree. The area of corpus callosum was measured directly by the autmeas soft ware on MRI, and the levels of p-tau and A151.42 in CSF were assaied by enzyme-labeled immunosorbent assay (ELISA). Results the levels of p-tau in CSF in AD1 group was(25. 8 ± 3. 1 ) pg/ml, which was higher than that of sex- and age-matched normal control ( 17.7 ± 1.5) pg/ml, and the level of A151.42 in AD1 group was (329.3 ± 15.2) pg/ml, which was lower than that of normal control (522. 5 ± 15.1) pg/ml. AD1 group has a mild corpus callosum shrink. There was a remarkably corpus callosum shrinke in AD2 group, especially at the area of the head and body of callus. The level of p-tau increased and the level of Aβ1-42 decreased remarkably in AD2 group (31.3 ± 4. 8) pg/ml and (318.5 ± 30.8) pg/ml than that in AD1 group. Conclusions The corpus callosum measurement combined with the p-tau and Aβ1-42 assay was useful in early AD diagnosis. Moreover, it was helpful to evaluate AD proceeding.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2007年第1期23-26,共4页 Chinese Journal of Neurology
基金 国家自然科学基金(30370494) 国家博士后基金(2004036272)
关键词 阿尔茨海默病 胼胝体 脑脊髓液 TAU蛋白质类 淀粉样Β蛋白 肽碎片 Alzheimer disease Corpus callosum Cerebrospinal fluid tau proteins Amyloid beta-protein Peptide fragments
  • 相关文献

参考文献8

  • 1Pogarell O,Teipel SJ,Juckel G,et al.EEG coherence reflects regional corpus callosum area in Alzheimer's disease.J Neurol Neurosurg Psychiatry,2005,76:109-111. 被引量:1
  • 2Gootjes L,Bouma A,Van Strien JW,et al.Corpus callosum size correlates with asymmetric performance on a dichotic listening task in healthy aging but not in Alzheimer's disease.Neuropsychologia,2006,44:208-217. 被引量:1
  • 3Jia JP,Meng R,Sun YX,et al.Cerebrospinal fluid tau,Aβ1-42and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia.Neurosci Lett,2005,383:12-16. 被引量:1
  • 4陈少琼,姚志彬,全显跃,梁碧玲,宁方芹.老年性痴呆患者胼胝体形态的磁共振影像研究[J].中华老年医学杂志,2000,19(6):456-457. 被引量:1
  • 5王亮,李坤成.血管性痴呆的MRI定量研究[J].中华放射学杂志,2000,34(11):738-741. 被引量:14
  • 6Kido DK,Caine ED,Lemay M,et al.Temporal lobe atrophy in patients with Alzheimer disease.Am J Neuroradiol,1989,10:551. 被引量:1
  • 7Teipel SJ,Bayer W,Alexander GE,et al.Progression of corpus callosum atrophy in Alzheimer disease.Arch Neurol,2002,59:243-248. 被引量:1
  • 8Hampel H,Goernitz A,Buerger K.Advances in the development of biomarkers for Alzheimer's disease:from CSF total tau and Abeta(1-42) proteins to phosphorylated tau protein.Brain Res Bull,2003,61:243-253. 被引量:1

二级参考文献2

  • 1魏孝琴 陈久荣 等.胼胝体形态学的临床应用与裂脑人[J].中国医科大学学报,1986,15:176-181. 被引量:2
  • 2Liu C K,Neurology,1992年,42卷,138页 被引量:1

共引文献13

同被引文献43

  • 1李毅,张中兴,吕路线,郝伟,丁新生.阿尔茨海默病与血管性痴呆患者脑脊液tau蛋白及β-淀粉样蛋白_(1-42)浓度的对照研究[J].中华精神科杂志,2004,37(4):220-223. 被引量:7
  • 2薛海波,肖世富,孙云,张明园.脑脊液生物学标志物诊断阿尔茨海默病与血管性痴呆[J].中国现代神经疾病杂志,2007,7(3):257-261. 被引量:5
  • 3Garcia-Alloza M,Robbins EM,Zhang-Nunes SX,et al.Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease.Neurobiol Dis,2006,24:516-524. 被引量:1
  • 4Smith MA,Harris PL,Sayre LM,et al.Iron accumulation in Alzheimer disease is a source of redox-generated free radicals.Proc Natl Acad Sci U S A,1997,94:9866-9868. 被引量:1
  • 5Smith MA.Oxidative stress and iron imbalance in Alzheimer disease:how rust became the fuss! J Alzheimers Dis,2006,9 (3Suppl):305-308. 被引量:1
  • 6Nunomura A,Perry G,Aliev G,et al.Oxidative damage is the earliest event in Alzheimer disease.J Neuropathol Exp Neurol,2001,60:759-767. 被引量:1
  • 7El Tannir El Tayara N,Delatour B,Le Cudennec C,et al.Agerelated evolution of amyloid burden,iron load,and MR relaxation times in a transgenic mouse model of Alzheimer's disease.Neurobiol Dis,2006,22:199-208. 被引量:1
  • 8El Tayara Nel T,Volk A,Dhenain M,et al.Transverse relaxation time reflects brain amyloidosis in young APP/PS1 transgenic mice.Magn Reson Med,2007,58:179-184. 被引量:1
  • 9Faber C,Zahneisen B,Tippmann F,et al.Gradient-echo and CRAZED imaging for minute detection of Alzheimer plaques in an APPV717I x ADAM10-dn mouse model.Magn Reson Med,2007,57:696-703. 被引量:1
  • 10Zhu WZ,Zhong WD,Wang W,et al.Quantitative MR phasecorrected imaging to investigate increased brain iron deposition of patients with Alzheimer disease.Radiology,2009,253:497-504. 被引量:1

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部